TIMI (Thrombolytics and Myocardial Infarction Study) Troponin-I data guide interventionists:
This article was originally published in Clinica
Heart attack patients with raised troponin-I should be treated more aggressively, according to data from the TIMI-IIIB trial (Thrombolytics and Myocardial Infarction Study). Patients with elevated levels had a significantly better outcome if they underwent early intervention rather than a conservative strategy of catheterisation followed by intervention, said Dr Elliot Antman of the Brigham & Women's Hospital during a presentation at the American Heart Association's annual meeting (Anaheim, California). For every ng/ml that troponin-I increased, mortality rose 10%.